title: Lots of enthusiasm, lots of questions.
abstract: Value-based benefit design is all the rage, but applying it to biologics is complicated. Several issues must be addressed if VBBD is to rule this frontier.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Dalzell